BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25468746)

  • 1. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review.
    Malietzis G; Aziz O; Bagnall NM; Johns N; Fearon KC; Jenkins JT
    Eur J Surg Oncol; 2015 Feb; 41(2):186-96. PubMed ID: 25468746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life.
    van Roekel EH; Bours MJL; Te Molder MEM; Breedveld-Peters JJL; Olde Damink SWM; Schouten LJ; Sanduleanu S; Beets GL; Weijenberg MP
    Qual Life Res; 2017 Jul; 26(7):1745-1759. PubMed ID: 28315175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of sarcopenia as a prognostic indicator in patients undergoing abdominal wall hernia repairs: a systematic review of the literature.
    Clark ST; Malietzis G; Grove TN; Jenkins JT; Windsor ACJ; Kontovounisios C; Warren OJ
    Hernia; 2020 Dec; 24(6):1361-1370. PubMed ID: 32300901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
    Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
    Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of body composition profile on outcomes following colorectal cancer surgery.
    Malietzis G; Currie AC; Athanasiou T; Johns N; Anyamene N; Glynne-Jones R; Kennedy RH; Fearon KC; Jenkins JT
    Br J Surg; 2016 Apr; 103(5):572-80. PubMed ID: 26994716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of body composition on chemotherapy toxicities in non-metastatic colorectal cancer patients: a systematic review.
    Choi CS; Kin K; Cao K; Hutcheon E; Lee M; Chan STF; Arafat Y; Baird PN; Yeung JMC
    ANZ J Surg; 2024 Mar; 94(3):327-334. PubMed ID: 38059530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review.
    Gibson DJ; Burden ST; Strauss BJ; Todd C; Lal S
    Eur J Clin Nutr; 2015 Oct; 69(10):1079-86. PubMed ID: 25782424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
    Hopkins JJ; Skubleny D; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Ann Surg Oncol; 2018 May; 25(5):1381-1394. PubMed ID: 29488190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the intestinal microbiome in colorectal cancer surgery outcomes.
    Lauka L; Reitano E; Carra MC; Gaiani F; Gavriilidis P; Brunetti F; de'Angelis GL; Sobhani I; de'Angelis N
    World J Surg Oncol; 2019 Dec; 17(1):204. PubMed ID: 31791356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of CT-Quantified Body Composition on Longitudinal Health-Related Quality of Life in Colorectal Cancer Patients: The Colocare Study.
    Gigic B; Nattenmüller J; Schneider M; Kulu Y; Syrjala KL; Böhm J; Schrotz-King P; Brenner H; Colditz GA; Figueiredo JC; Grady WM; Li CI; Shibata D; Siegel EM; Toriola AT; Kauczor HU; Ulrich A; Ulrich CM
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32353960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia and obesity among patients with soft tissue sarcoma - Association with clinicopathologic characteristics, complications and oncologic outcome: A systematic review and meta-analysis.
    Barnes ME; Elliott JA; McIntyre TV; Boyle EA; Gillis AE; Ridgway PF
    Eur J Surg Oncol; 2021 Sep; 47(9):2237-2247. PubMed ID: 34023166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
    Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
    ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer.
    van Vugt JLA; Coebergh van den Braak RRJ; Lalmahomed ZS; Vrijland WW; Dekker JWT; Zimmerman DDE; Vles WJ; Coene PLO; IJzermans JNM
    Eur J Surg Oncol; 2018 Sep; 44(9):1354-1360. PubMed ID: 29914788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients.
    Cespedes Feliciano EM; Popuri K; Cobzas D; Baracos VE; Beg MF; Khan AD; Ma C; Chow V; Prado CM; Xiao J; Liu V; Chen WY; Meyerhardt J; Albers KB; Caan BJ
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1258-1269. PubMed ID: 32314543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.